NADAL® GBS (Strep B) PCR Test

Clinical Laboratory

NADAL® GBS (Strep B) PCR Test 2710506

nal von Minden · 2710506

Article No. AK-CL-453

Product details

Article number
AK-CL-453
Category
Clinical Laboratory
Brand
nal von Minden
Model
2710506

Description

With the NADAL® GBS (Strep B) PCR Test, you can reliably and quickly detect colonisation with Group B Streptococci (GBS) in pregnant patients. This preventive measure is particularly important to minimise the risk for the newborn and to enable timely initiation of therapeutic measures. The test offers you significantly higher accuracy than conventional rapid tests and provides a clear, qualitative result within just 15 to 35 minutes. This allows you to make well-founded decisions regarding further treatment – directly in your practice, without having to wait long for laboratory results. Thanks to the PCR-based detection method and the simple handling with the supplied sampling kits, you can effortlessly integrate the test into your practice workflows. The procedure is straightforward: take the vaginal swab, prepare the sample with just a few simple steps, and conveniently have the result analysed by the appropriate NADAL® PCR Analyzer. Work simplification and time savings are the main priorities – you offer your patient and her child maximum safety, without complicating your daily work in the medical practice. The included, easy-to-understand instructions for use support you step b

Request a quotation

Equipment standard by AKLION — configuration, accessories and lead time are confirmed on the quotation.

Technical specifications

Brand
nal von Minden
Model
2710506
Product type
Analysis Device Test Strips
Detected parameter
Group B Streptococci (GBS), DNA detection
Test format
PCR test cassette, qualitative
Sample material
Vaginal swab
Test evaluation
Result within 15 to 35 minutes
Cut-off
1000 CFU/mL
Required devices
NADAL® PCR Analyzer PRO1 or PRO8 (not included)
Storage temperature
2 °C to 30 °C
Shelf life
13 months
CE marking
Yes
Pathogen type
Bacterial infection
Detection of
Antigen
Application
Qualitative in vitro detection in pregnant women (35th–37th week of gestation)
Test principle
Isothermal amplification technology and enzyme degradation probe technology
Internal control
Yes, to monitor all test steps